Rare Diseases Day: Unspent Funds, Untreated Patients Cause Concern
Despite policy and budget, rare disease patients face treatment interruptions due to unspent funds.
Photo by Danish Pandit
Approximately ₹271 crore allocated for rare disease patients in India remains unspent, raising concerns on Rare Diseases Day. Despite a notified policy for rare diseases, designated Centres of Excellence, and a dedicated budget, many children are experiencing deteriorating health due to treatment interruptions. For the year 2025–26, ₹299 crore was allocated for rare disease treatment, but only ₹30.79 crore has been utilized by the National Policy for Rare Diseases (NPRD) so far. Nearly 2,000 rare disease patients across India are awaiting treatment, including around 450 eligible patients with life-threatening Lysosomal Storage Disorders (LSD).
This situation highlights the challenges in effectively implementing policies and utilizing allocated funds to address the urgent needs of rare disease patients. The lack of access to timely treatment can have severe consequences, especially for children with rare diseases.
This issue is relevant to India's healthcare system and social justice concerns, making it important for UPSC aspirants to understand the challenges in implementing health policies and ensuring equitable access to healthcare. This topic is relevant to UPSC General Studies Paper II (Social Justice and Governance) and Paper III (Healthcare).
Key Facts
A notified policy for rare diseases is in place in India.
Centres of Excellence (CoEs) have been established across the country.
A budget exists to assist with the treatment of rare diseases.
Many children are experiencing deteriorating health due to treatment interruptions.
UPSC Exam Angles
UPSC General Studies Paper II (Social Justice and Governance): Government policies and interventions for the vulnerable sections of the population.
UPSC General Studies Paper III (Healthcare): Issues relating to health, disease, and the healthcare system.
Potential question types: Analyzing the effectiveness of government policies, challenges in healthcare delivery, and the role of civil society in addressing health issues.
In Simple Words
Rare diseases are uncommon illnesses that often require specialized and costly treatments. In India, there's a special fund to help people with these diseases, but a lot of that money isn't being used. This means many patients aren't getting the care they need, even though the funds are available.
India Angle
In India, many families struggle to afford treatment for rare diseases, pushing them into debt. The unspent funds could provide crucial support, but bureaucratic hurdles and policy gaps prevent the money from reaching those who need it most.
For Instance
Think of it like a community library with a grant for buying new books, but the librarian doesn't order them. People who rely on the library miss out, even though the resources are there.
This affects everyone because it shows how government funds aren't always used effectively, impacting the health and well-being of vulnerable people. It highlights the need for better healthcare access and policy implementation.
Unused funds mean untreated patients: Money matters, but action matters more.
On Rare Diseases Day, concerns are raised about the unspent budget and untreated patients in India. Despite a notified policy for rare diseases, Centres of Excellence, and a budget for treatment, approximately ₹271 crore allocated for rare disease patients remains unused. Many children are experiencing deteriorating health due to treatment interruptions.
For the year 2025–26, ₹299 crore was allocated for rare disease treatment, but only ₹30.79 crore has been utilized by the NPRD so far. Nearly 2,000 rare disease patients across India are awaiting treatment, including around 450 eligible patients with life-threatening Lysosomal Storage Disorders (LSD).
Expert Analysis
The unspent funds allocated for rare diseases in India highlight critical gaps in healthcare policy implementation and resource utilization. To fully understand this situation, several key concepts need to be examined.
The National Policy for Rare Diseases, 2021 aimed to increase awareness, facilitate early diagnosis, and provide financial support for the treatment of rare diseases. However, the fact that ₹271 crore remains unspent indicates systemic issues in the policy's execution. This could be due to bureaucratic delays, lack of awareness among potential beneficiaries, or stringent eligibility criteria that limit access to funds. The policy's success hinges on effective implementation and the ability to reach those who need it most. The policy categorized rare diseases into three groups based on treatability and cost, aiming to provide differential support. The current situation suggests a re-evaluation of these categories and the support mechanisms is needed.
Centres of Excellence (CoEs) were established under the NPRD to provide comprehensive care, including diagnosis, treatment, and research for rare diseases. The underutilization of funds suggests that these CoEs may not be fully functional or accessible to patients across the country. The CoEs are intended to be hubs for expertise and resources, but their effectiveness is limited if patients cannot access them or if they lack the necessary infrastructure and trained personnel. The lack of utilization of allocated funds, despite the presence of CoEs, points to a disconnect between policy intent and ground reality.
Lysosomal Storage Disorders (LSDs) are a group of rare, inherited metabolic disorders that result from defects in lysosomal function. The fact that 450 eligible patients with life-threatening LSDs are awaiting treatment underscores the urgency of the situation. LSDs often require lifelong treatment, which can be extremely expensive. The lack of access to treatment can lead to irreversible damage and premature death, especially in children. The NPRD's financial assistance scheme is crucial for these patients, but the unspent funds indicate that the scheme is not reaching those who need it most.
For UPSC aspirants, understanding the challenges in implementing healthcare policies, particularly for vulnerable populations like rare disease patients, is crucial. This issue touches upon social justice, governance, and healthcare, all of which are important components of the UPSC syllabus. Questions related to the NPRD, the role of CoEs, and the challenges in providing affordable treatment for rare diseases can be asked in both prelims and mains exams.
Visual Insights
Rare Diseases: Key Statistics
Key statistics related to rare diseases in India, highlighting the unspent funds and the number of patients awaiting treatment.
- Unspent Funds for Rare Diseases
- ₹271 crore
- Funds Utilized in 2025-26
- ₹30.79 crore
- Rare Disease Patients Awaiting Treatment
- 2,000
- LSD Patients Awaiting Treatment
- 450
Significant amount of allocated funds remains unused, hindering treatment for patients.
Out of ₹299 crore allocated, only a small portion has been utilized.
A large number of patients are waiting for treatment, including those with life-threatening conditions.
These patients suffer from life-threatening Lysosomal Storage Disorders and require urgent treatment.
More Information
Background
Latest Developments
Frequently Asked Questions
1. Why are funds allocated for rare diseases going unspent, especially when patients urgently need treatment?
Several factors contribute to the underutilization of funds. These include:
- •Complex approval processes for disbursing funds to individual patients.
- •Limited awareness among patients and healthcare providers about the availability of financial assistance.
- •Delays in identifying and diagnosing rare disease patients who are eligible for support.
- •Stringent eligibility criteria that may exclude some deserving patients.
Exam Tip
Remember the key stakeholders involved: patients, healthcare providers, government agencies. A balanced answer should address the challenges faced by each.
2. What's the difference between Centres of Excellence (CoEs) and the National Policy for Rare Diseases (NPRD)?
The NPRD is a broad policy framework, while CoEs are specific institutions established to implement the policy's objectives.
- •NPRD: Aims to create a comprehensive system for the diagnosis, prevention, and treatment of rare diseases.
- •CoEs: Function as specialized treatment centers, providing expert care and conducting research on rare diseases.
- •NPRD: Sets guidelines for financial assistance, awareness campaigns, and research initiatives.
- •CoEs: Directly involved in patient care, diagnosis, and research activities, utilizing the NPRD framework.
Exam Tip
Don't confuse the policy with the implementing bodies. NPRD is the 'what,' CoEs are the 'where' and 'how'.
3. If UPSC asks about the National Policy for Rare Diseases (NPRD), what's a common trap they might set in the Prelims?
A common trap is to misrepresent the scope of financial assistance. UPSC might suggest that the NPRD covers all rare diseases or provides unlimited funding, which isn't true.
- •The NPRD focuses on specific categories of rare diseases.
- •Financial assistance is subject to budgetary constraints and eligibility criteria.
- •Be wary of extreme statements like 'all' or 'unlimited' when it comes to policy coverage.
Exam Tip
Pay close attention to qualifying words like 'primarily,' 'only,' 'up to,' and 'may' in the question stem. These can significantly alter the meaning.
4. How does the underutilization of funds for rare diseases affect India's healthcare system and Sustainable Development Goals (SDGs)?
The underutilization of funds negatively impacts India's healthcare system and SDGs by:
- •Hindering progress towards SDG 3 (Good Health and Well-being) by denying treatment to vulnerable populations.
- •Straining healthcare infrastructure as patients' conditions worsen due to lack of timely intervention.
- •Increasing the burden on families and caregivers, affecting their economic productivity and overall well-being.
- •Undermining public trust in the healthcare system's ability to address rare and complex medical conditions.
Exam Tip
Link the issue to broader development goals. Show how neglecting rare diseases can have cascading effects on other sectors.
5. What are the ethical considerations surrounding the treatment of rare diseases in India, given limited resources?
Ethical considerations include:
- •Prioritization of patients: How to fairly allocate limited funds among a large pool of eligible patients.
- •Equity and access: Ensuring that patients from marginalized communities have equal access to treatment.
- •Transparency and accountability: Maintaining transparency in the decision-making process for fund allocation.
- •Informed consent: Ensuring that patients and their families are fully informed about the risks and benefits of available treatments.
Exam Tip
Consider the principles of distributive justice and utilitarianism when analyzing the ethical dimensions of this issue.
6. How can the government improve the implementation of the National Policy for Rare Diseases (NPRD) and ensure that allocated funds are effectively utilized?
The government can improve implementation by:
- •Streamlining the approval process for financial assistance to reduce delays.
- •Increasing awareness among healthcare providers and the public about the NPRD and available resources.
- •Strengthening the capacity of Centres of Excellence (CoEs) to diagnose and treat rare diseases.
- •Establishing a robust monitoring and evaluation mechanism to track the utilization of funds and the outcomes of treatment.
Exam Tip
Focus on actionable steps and measurable outcomes. Avoid vague suggestions and emphasize practical solutions.
7. What specific fact about the unspent funds could be twisted into a tricky MCQ for Prelims?
UPSC could ask: 'Approximately how much of the funds allocated for rare disease patients in India remains unspent?' and offer close options like ₹200 crore, ₹250 crore, ₹271 crore, and ₹300 crore.
Exam Tip
Memorize the exact figure: ₹271 crore. Examiners love to test your recall of specific numbers.
8. How does this news about unspent funds for rare diseases relate to broader issues of healthcare access and equity in India?
This situation highlights systemic challenges in ensuring equitable healthcare access:
- •It exemplifies the difficulties in translating policy intentions into tangible benefits for vulnerable populations.
- •It underscores the need for stronger monitoring mechanisms to ensure that funds reach intended beneficiaries.
- •It reflects broader issues of bureaucratic delays and inefficiencies in the healthcare system.
Exam Tip
Connect the specific issue to larger themes like social justice, governance, and public health policy.
9. If a Mains question asks to 'critically examine' the National Policy for Rare Diseases, what two opposing viewpoints should I present?
Present these opposing viewpoints:
- •Positive: The NPRD represents a significant step forward in addressing the needs of rare disease patients by providing a policy framework and dedicated funding.
- •Negative: The NPRD's implementation has been hampered by bureaucratic delays, stringent eligibility criteria, and a lack of awareness, resulting in unspent funds and unmet needs.
Exam Tip
Always offer a balanced perspective. Acknowledge the policy's potential while highlighting its shortcomings.
10. What are the implications of the funding ceiling being crossed for some patients in August 2024?
The implications are:
- •Treatment interruptions: Patients may face disruptions in their ongoing treatment due to lack of funds.
- •Deteriorating health: Interrupted treatment can lead to a worsening of their medical conditions.
- •Increased financial burden: Families may have to bear the cost of treatment themselves, leading to financial strain.
- •Loss of confidence: Patients and their families may lose confidence in the government's ability to provide continuous support.
Exam Tip
Remember the date (August 2024) as it signifies a critical point when the funding mechanism started to falter for some patients.
Practice Questions (MCQs)
1. Consider the following statements regarding the National Policy for Rare Diseases, 2021: 1. It aims to increase awareness and facilitate early diagnosis of rare diseases. 2. It provides financial support primarily for rare diseases amenable to one-time curative treatment. 3. It establishes Centres of Excellence for comprehensive care and research. Which of the statements given above is/are correct?
- A.1 and 2 only
- B.2 and 3 only
- C.1 and 3 only
- D.1, 2 and 3
Show Answer
Answer: D
All three statements are correct regarding the National Policy for Rare Diseases, 2021. Statement 1 is correct as the policy aims to increase awareness and facilitate early diagnosis. Statement 2 is correct as financial support is primarily focused on diseases amenable to one-time curative treatment. Statement 3 is correct as the policy establishes Centres of Excellence for comprehensive care and research.
2. In the context of rare diseases in India, consider the following: Assertion (A): Despite a dedicated budget, a significant portion of funds allocated for rare disease patients remains unspent. Reason (R): Lack of awareness among potential beneficiaries and bureaucratic delays hinder the effective utilization of funds. In the light of the above, which one of the following is correct?
- A.Both A and R are true and R is the correct explanation of A
- B.Both A and R are true but R is NOT the correct explanation of A
- C.A is true but R is false
- D.A is false but R is true
Show Answer
Answer: A
Both the assertion and the reason are true, and the reason correctly explains the assertion. A significant portion of funds remains unspent, and this is due to factors such as lack of awareness and bureaucratic delays, which hinder the effective utilization of funds for rare disease patients.
3. Which of the following statements is NOT correct regarding Lysosomal Storage Disorders (LSDs)?
- A.They are a group of rare, inherited metabolic disorders.
- B.They result from defects in lysosomal function.
- C.They often require lifelong treatment.
- D.They are easily curable with a short course of medication.
Show Answer
Answer: D
Statement D is NOT correct. Lysosomal Storage Disorders (LSDs) are not easily curable with a short course of medication. They often require lifelong treatment and management due to their chronic and progressive nature.
Source Articles
A budget that remains unspent, patients remain untreated, crisis brews, this Rare Diseases Day - The Hindu
India’s fight against rare diseases - The Hindu
Appeal to Union health ministry to release fund to treat rare diseases - The Hindu
Extent of under-utilisation of funds for rare diseases is revealed in Lok Sabha - The Hindu
Early diagnosis, affordability of treatment continue to remain hurdles in tackling rare diseases in India - The Hindu
About the Author
Richa SinghSocial Issues Enthusiast & Current Affairs Writer
Richa Singh writes about Social Issues at GKSolver, breaking down complex developments into clear, exam-relevant analysis.
View all articles →